University of Oxford has launched a large study to investigate the use of Ivermectin for Covid-19 treatment, amid guidelines across the world, warning against the use of the drug.
Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 250 million vials of Sputnik V in India. It has already received nearly 3 million doses.
Dr Balram Bhargava told the panel that ICMR is entitled to 5% royalty on sale price of Covaxin & said it could be possible to break chain of infection if 30% of people get even 1 dose.
Conducted by ICMR-National Institute of Epidemiology, the analysis uses data documented by Tamil Nadu Police department. It was published in Indian Journal of Medical Research.
ThePrint brings you some important global stories on the coronavirus pandemic.
Health ministry Tuesday had announced the Delta variant as a 'variant of concern'. The three states have been advised to strengthen surveillance.
Task force member Shashank Joshi said there is no sufficient data on Delta plus variant of concern to be alarmed except that Covid appropriate behaviour & vaccination must continue.
The death toll climbed to 3,90,660 with 1,358 fresh fatalities, while the recovery rate further improved to 96.56 %, as per health ministry data.
Govt's KIRAN helpline was started in September 2020. Until 31 May, report shows nearly 30,000 calls were received. Callers discussed issues related to anxiety, depression, job loss, etc.
Initial preliminary studies have shown that Ivermectin can reduce viral load, the amount of virus in the respiratory tract, and the length of symptoms in people with mild infection.